0001209191-19-041772.txt : 20190711
0001209191-19-041772.hdr.sgml : 20190711
20190711090124
ACCESSION NUMBER: 0001209191-19-041772
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190710
FILED AS OF DATE: 20190711
DATE AS OF CHANGE: 20190711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Scott Andrew
CENTRAL INDEX KEY: 0001614975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 19950414
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-10
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001614975
Smith Scott Andrew
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
1
0
0
0
Stock Option (right to buy)
4.62
2019-07-10
4
A
0
7500
0.00
A
2029-07-09
Common Stock
7500
7500
D
Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on July 10, 2019, the date of the Issuer's 2019 Annual Meeting of Stockholder, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
/s/ Lori Firmani, attorney-in-fact
2019-07-11